IRIS Accounts Production v25.1.3.33 03991151 director 1.1.24 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh039911512023-12-31039911512024-12-31039911512024-01-012024-12-31039911512022-12-31039911512023-01-012023-12-31039911512023-12-3103991151ns15:EnglandWales2024-01-012024-12-3103991151ns14:PoundSterling2024-01-012024-12-3103991151ns10:Director12024-01-012024-12-3103991151ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3103991151ns10:SmallEntities2024-01-012024-12-3103991151ns10:AuditExemptWithAccountantsReport2024-01-012024-12-3103991151ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3103991151ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3103991151ns10:FullAccounts2024-01-012024-12-3103991151ns10:RegisteredOffice2024-01-012024-12-3103991151ns5:CurrentFinancialInstruments2024-12-3103991151ns5:CurrentFinancialInstruments2023-12-3103991151ns5:ShareCapital2024-12-3103991151ns5:ShareCapital2023-12-3103991151ns5:RetainedEarningsAccumulatedLosses2024-12-3103991151ns5:RetainedEarningsAccumulatedLosses2023-12-3103991151ns5:LandBuildingsns5:OwnedOrFreeholdAssets2024-01-012024-12-3103991151ns5:LandBuildingsns5:ShortLeaseholdAssets2024-01-012024-12-3103991151ns5:LeaseholdImprovements2024-01-012024-12-3103991151ns5:PlantMachinery2024-01-012024-12-3103991151ns5:FurnitureFittings2024-01-012024-12-3103991151ns5:MotorVehicles2024-01-012024-12-3103991151ns5:ComputerEquipment2024-01-012024-12-3103991151ns5:LandBuildings2023-12-3103991151ns5:LandBuildingsns5:ShortLeaseholdAssets2023-12-3103991151ns5:LeaseholdImprovements2023-12-3103991151ns5:PlantMachinery2023-12-3103991151ns5:LandBuildings2024-01-012024-12-3103991151ns5:LandBuildings2024-12-3103991151ns5:LandBuildingsns5:ShortLeaseholdAssets2024-12-3103991151ns5:LeaseholdImprovements2024-12-3103991151ns5:PlantMachinery2024-12-3103991151ns5:LandBuildings2023-12-3103991151ns5:LandBuildingsns5:ShortLeaseholdAssets2023-12-3103991151ns5:LeaseholdImprovements2023-12-3103991151ns5:PlantMachinery2023-12-3103991151ns5:FurnitureFittings2023-12-3103991151ns5:MotorVehicles2023-12-3103991151ns5:ComputerEquipment2023-12-3103991151ns5:FurnitureFittings2024-12-3103991151ns5:MotorVehicles2024-12-3103991151ns5:ComputerEquipment2024-12-3103991151ns5:FurnitureFittings2023-12-3103991151ns5:MotorVehicles2023-12-3103991151ns5:ComputerEquipment2023-12-3103991151ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3103991151ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31039911511ns10:Director12023-12-31039911511ns10:Director12022-12-31039911511ns10:Director12024-01-012024-12-31039911511ns10:Director12023-01-012023-12-31039911511ns10:Director12024-12-31039911511ns10:Director12023-12-31
















LOMACK-HEALTH COMPANY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31ST DECEMBER 2024






LOMACK-HEALTH COMPANY LIMITED (REGISTERED NUMBER: 03991151)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Accountants' Report 6

LOMACK-HEALTH COMPANY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2024







DIRECTOR: Dr L O Odunsi





REGISTERED OFFICE: 162 Bedford Road
Kempston
Bedford
Bedfordshire
MK42 8BH





REGISTERED NUMBER: 03991151 (England and Wales)





ACCOUNTANTS: HW Bedford Limited
Trading as Haines Watts
First Floor, Woburn Court
2 Railton Road
Woburn Rd Ind Est
Kempston
Bedfordshire
MK42 7PN

LOMACK-HEALTH COMPANY LIMITED (REGISTERED NUMBER: 03991151)

BALANCE SHEET
31ST DECEMBER 2024

31/12/24 31/12/23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 1,029,887 1,067,713

CURRENT ASSETS
Debtors 5 1,104,024 1,064,278
Cash at bank and in hand 70,606 40,565
1,174,630 1,104,843
CREDITORS
Amounts falling due within one year 6 93,925 83,338
NET CURRENT ASSETS 1,080,705 1,021,505
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,110,592

2,089,218

PROVISIONS FOR LIABILITIES 3,439 5,155
NET ASSETS 2,107,153 2,084,063

CAPITAL AND RESERVES
Called up share capital 49 49
Retained earnings 2,107,104 2,084,014
2,107,153 2,084,063

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 5th August 2025 and were signed by:



Dr L O Odunsi - Director


LOMACK-HEALTH COMPANY LIMITED (REGISTERED NUMBER: 03991151)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

1. STATUTORY INFORMATION

Lomack-Health Company Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Short leasehold - straight line over lease term
Improvements to property - 10% on cost
Medical equipment - 25% on reducing balance
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

LOMACK-HEALTH COMPANY LIMITED (REGISTERED NUMBER: 03991151)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 30 (2023 - 31 ) .

4. TANGIBLE FIXED ASSETS
Improvements
Freehold Short to Medical
property leasehold property equipment
£    £    £    £   
COST
At 1st January 2024 1,442,834 40,431 100,119 16,355
Additions - - - -
Disposals - - - -
At 31st December 2024 1,442,834 40,431 100,119 16,355
DEPRECIATION
At 1st January 2024 422,177 40,431 99,569 16,284
Charge for year 28,856 - 550 18
Eliminated on disposal - - - -
At 31st December 2024 451,033 40,431 100,119 16,302
NET BOOK VALUE
At 31st December 2024 991,801 - - 53
At 31st December 2023 1,020,657 - 550 71

Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1st January 2024 95,689 134,806 57,949 1,888,183
Additions 2,384 - 1,465 3,849
Disposals - - (1,118 ) (1,118 )
At 31st December 2024 98,073 134,806 58,296 1,890,914
DEPRECIATION
At 1st January 2024 89,143 97,079 55,787 820,470
Charge for year 1,750 9,433 1,068 41,675
Eliminated on disposal - - (1,118 ) (1,118 )
At 31st December 2024 90,893 106,512 55,737 861,027
NET BOOK VALUE
At 31st December 2024 7,180 28,294 2,559 1,029,887
At 31st December 2023 6,546 37,727 2,162 1,067,713

LOMACK-HEALTH COMPANY LIMITED (REGISTERED NUMBER: 03991151)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/24 31/12/23
£    £   
Amounts owed by group undertakings 1,103,369 1,021,586
Directors' current accounts - 42,381
Prepayments and accrued income 655 311
1,104,024 1,064,278

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/24 31/12/23
£    £   
Trade creditors 1,161 8,613
Corporation tax 49,332 31,220
Social security and other taxes 15,826 15,549
Other creditors 20,064 25,549
Pensions payable 2,776 -
Directors' current accounts 359 -
Accruals and deferred income 4,407 2,407
93,925 83,338

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st December 2024 and 31st December 2023:

31/12/24 31/12/23
£    £   
Dr L O Odunsi
Balance outstanding at start of year 42,381 61,780
Amounts advanced 38,531 -
Amounts repaid (80,912 ) (19,399 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - 42,381

ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
LOMACK-HEALTH COMPANY LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Statement of Comprehensive Income and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Lomack-Health Company Limited for the year ended 31st December 2024 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Lomack-Health Company Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Lomack-Health Company Limited and state those matters that we have agreed to state to the director of Lomack-Health Company Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Lomack-Health Company Limited and its director for our work or for this report.

It is your duty to ensure that Lomack-Health Company Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Lomack-Health Company Limited. You consider that Lomack-Health Company Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Lomack-Health Company Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






HW Bedford Limited
Trading as Haines Watts
First Floor, Woburn Court
2 Railton Road
Woburn Rd Ind Est
Kempston
Bedfordshire
MK42 7PN


5th August 2025